| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 485 | 2021 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 254 | 2022 |
| Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group S Stacchiotti, A Gronchi, P Fossati, T Akiyama, C Alapetite, M Baumann, ... Annals of Oncology 28 (6), 1230-1242, 2017 | 203 | 2017 |
| Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ... Annals of Oncology 32 (12), 1520-1536, 2021 | 180 | 2021 |
| Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network GD Demetri, CR Antonescu, B Bjerkehagen, JVMG Bovee, K Boye, ... Annals of oncology 31 (11), 1506-1517, 2020 | 121 | 2020 |
| Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial J Martin-Broto, S Stacchiotti, A Lopez-Pousa, A Redondo, D Bernabeu, ... The Lancet Oncology 20 (1), 134-144, 2019 | 109 | 2019 |
| Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial J Martin-Broto, N Hindi, G Grignani, J Martinez-Trufero, A Redondo, ... Journal for immunotherapy of cancer 8 (2), 2020 | 99 | 2020 |
| Imatinib in advanced chordoma: a retrospective case series analysis N Hindi, PG Casali, C Morosi, A Messina, E Palassini, S Pilotti, ... European journal of cancer 51 (17), 2609-2614, 2015 | 91 | 2015 |
| Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts S Stacchiotti, AB Miah, AM Frezza, C Messiou, C Morosi, A Caraceni, ... ESMO open 6 (3), 100170, 2021 | 86 | 2021 |
| Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas) R Sanfilippo, RL Jones, JY Blay, A Le Cesne, S Provenzano, G Antoniou, ... Clinical Cancer Research 25 (17), 5295-5300, 2019 | 85 | 2019 |
| A comprehensive review on solitary fibrous tumor: new insights for new horizons J Martin-Broto, JL Mondaza-Hernandez, DS Moura, N Hindi Cancers 13 (12), 2913, 2021 | 79 | 2021 |
| Activity of pazopanib and trabectedin in advanced alveolar soft part sarcoma S Stacchiotti, O Mir, A Le Cesne, B Vincenzi, A Fedenko, RG Maki, ... The oncologist 23 (1), 62-70, 2018 | 78 | 2018 |
| Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial J Martin-Broto, J Cruz, N Penel, A Le Cesne, N Hindi, P Luna, DS Moura, ... The Lancet Oncology 21 (3), 456-466, 2020 | 63 | 2020 |
| Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial S Stacchiotti, S Ferrari, A Redondo, N Hindi, E Palmerini, MAV Salgado, ... The Lancet Oncology 20 (9), 1252-1262, 2019 | 62 | 2019 |
| Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for … J Martin-Broto, A Redondo, C Valverde, MA Vaz, J Mora, XG Del Muro, ... Annals of Oncology 28 (12), 2994-2999, 2017 | 59 | 2017 |
| Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): results of a phase I study in myxoid liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups A Gronchi, N Hindi, J Cruz, JY Blay, A Lopez-Pousa, A Italiano, R Alvarez, ... EClinicalMedicine 9, 35-43, 2019 | 52 | 2019 |
| Relevance of reference centers in sarcoma care and quality item evaluation: results from the prospective registry of the Spanish Group for Research in Sarcoma (GEIS) J Martin‐Broto, N Hindi, J Cruz, J Martinez‐Trufero, C Valverde, ... The Oncologist 24 (6), e338-e346, 2019 | 51 | 2019 |
| SEOM Clinical Guideline of management of soft-tissue sarcoma (2016) A López-Pousa, J Martin Broto, J Martinez Trufero, I Sevilla, C Valverde, ... Clinical and translational oncology 18, 1213-1220, 2016 | 51 | 2016 |
| Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European … LH Lindner, S Litiere, S Sleijfer, C Benson, A Italiano, B Kasper, ... International journal of cancer 142 (12), 2610-2620, 2018 | 43 | 2018 |
| Assessment of safety and efficacy of combined trabectedin and low-dose radiotherapy for patients with metastatic soft-tissue sarcomas: a nonrandomized phase 1/2 clinical trial J Martin-Broto, N Hindi, A Lopez-Pousa, J Peinado-Serrano, R Alvarez, ... JAMA oncology 6 (4), 535-541, 2020 | 37 | 2020 |
